Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Gene | JAK1 |
Variant | V658I |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | JAK1 V658I lies within the protein kinase domain 1 of the Jak1 protein (UniProt.org). V658I results in constitutive Jak1 activation, increased phosphorylation of Stat5 and Erk, and is transforming in cell culture (PMID: 21393331). |
Associated Drug Resistance | |
Category Variants Paths |
JAK1 mutant JAK1 act mut JAK1 V658I |
Transcript | NM_002227.4 |
gDNA | chr1:g.64846664C>T |
cDNA | c.1972G>A |
Protein | p.V658I |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_002227 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321855.2 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321856.1 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321854 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321852.2 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321855.1 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_002227.4 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
XM_047419674.1 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321855 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_002227.3 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321852 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321852.1 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321853 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321856 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321854.1 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001320923 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
XM_047419675.1 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001320923.2 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321853.2 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321854.2 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321853.1 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001320923.1 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
NM_001321856.2 | chr1:g.64846664C>T | c.1972G>A | p.V658I | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
JAK1 V658I | cancer | sensitive | Ruxolitinib | Preclinical | Actionable | In a preclinical study, transformed cells harboring JAK1 V658I were sensitive to ATP-competetive JAK inhibitors, such as Jakafi (Ruxolitinib) (PMID: 21393331). | 21393331 |